Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2017 Nov 22;338:112–123. doi: 10.1016/j.taap.2017.11.014

Figure 4. Effects of PPARα activation and deficiency on the biliary excretion of BAs.

Figure 4

Individual BAs in the bile were quantified by UPLC-MS/MS, and the biliary excretion rate was normalized to body weight. Data represent means ± S.E.M. *p<0.05 versus vehicle treatment group; #p<0.05 versus WT group.